首页 > 最新文献

Biomaterials最新文献

英文 中文
Self-amplifying violet phosphorus-manganese nanocatalysts disrupt redox homeostasis and potentiate antitumor immunity via NIR-II phototherapy 自扩增紫色磷锰纳米催化剂通过NIR-II光疗破坏氧化还原稳态并增强抗肿瘤免疫。
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-23 DOI: 10.1016/j.biomaterials.2025.123872
Zhuo Mao , Yitong Zhang , Jingyue Xu , Hanyue Li , Tingxuan Li , Rourou Miao , Liu Yu , Meitong Ou , Ran Luo , Fan Zhang , Hanjie Zhang , Lin Mei
Nanocatalytic therapy holds great promise in tumor treatment. However, its antitumor efficacy is substantially hindered by limitations of the tumor microenvironment (TME), including substrate the type and concentration of substrates, pH value, antioxidant stress defense mechanisms, and immunosuppressive milieu. This study presents a nanoplatform composed of manganese-in-situ-mineralized violet phosphorus nanosheets (VPNSs), abbreviated as MVPs. This platform enables both the disruption of redox homeostasis and activation of antitumor immunity through regulation by the TME and near-infrared II region (NIR-II) light stimulation. Within MVPs, VPNSs not only function as electron donors to sustain the concentration of active Mn2+ in the TME and amplify the Mn2+-mediated self-enhanced chemodynamic therapy (CDT), but also serve as NIR-II photocatalysts. The photocatalytic properties synergistically elevate the level of reactive oxygen species (ROS) at the tumor site, thereby disrupting the redox homeostasis of tumor cells. Furthermore, the NIR-II photothermal characteristic of MVPs enhances the Mn2+-mediated activation of the stimulator of interferon genes (STING) pathway, endowing MVPs with antitumor immune activation capability. MVPs demonstrate excellent tumor therapeutic performance and biocompatibility in female tumor-bearing mice with a tumor inhibition rate of 85.24 %, achieving “catalysis-photothermal-immunity” synergistic antitumor activity.
纳米催化疗法在肿瘤治疗中具有广阔的应用前景。然而,其抗肿瘤作用受到肿瘤微环境(tumor microenvironment, TME)的限制,包括底物的类型和浓度、pH值、抗氧化应激防御机制、免疫抑制环境等。本文提出了一种由锰原位矿化紫磷纳米片(VPNSs)组成的纳米平台,简称mvp。该平台通过TME和近红外II区(NIR-II)光刺激调节,既可以破坏氧化还原稳态,又可以激活抗肿瘤免疫。在mvp中,VPNSs不仅作为电子供体维持TME中活性Mn2+的浓度并增强Mn2+介导的自增强化学动力学治疗(CDT),而且还作为NIR-II光催化剂。光催化特性协同提高肿瘤部位的活性氧(ROS)水平,从而破坏肿瘤细胞的氧化还原稳态。此外,MVPs的NIR-II光热特性增强了Mn2+介导的干扰素刺激因子(STING)通路的激活,赋予MVPs抗肿瘤免疫激活能力。mvp在雌性荷瘤小鼠中表现出良好的肿瘤治疗性能和生物相容性,肿瘤抑制率为85.24%,实现了“催化-光热-免疫”协同抗肿瘤活性。
{"title":"Self-amplifying violet phosphorus-manganese nanocatalysts disrupt redox homeostasis and potentiate antitumor immunity via NIR-II phototherapy","authors":"Zhuo Mao ,&nbsp;Yitong Zhang ,&nbsp;Jingyue Xu ,&nbsp;Hanyue Li ,&nbsp;Tingxuan Li ,&nbsp;Rourou Miao ,&nbsp;Liu Yu ,&nbsp;Meitong Ou ,&nbsp;Ran Luo ,&nbsp;Fan Zhang ,&nbsp;Hanjie Zhang ,&nbsp;Lin Mei","doi":"10.1016/j.biomaterials.2025.123872","DOIUrl":"10.1016/j.biomaterials.2025.123872","url":null,"abstract":"<div><div>Nanocatalytic therapy holds great promise in tumor treatment. However, its antitumor efficacy is substantially hindered by limitations of the tumor microenvironment (TME), including substrate the type and concentration of substrates, pH value, antioxidant stress defense mechanisms, and immunosuppressive milieu. This study presents a nanoplatform composed of manganese-in-situ-mineralized violet phosphorus nanosheets (VPNSs), abbreviated as MVPs. This platform enables both the disruption of redox homeostasis and activation of antitumor immunity through regulation by the TME and near-infrared II region (NIR-II) light stimulation. Within MVPs, VPNSs not only function as electron donors to sustain the concentration of active Mn<sup>2+</sup> in the TME and amplify the Mn<sup>2+</sup>-mediated self-enhanced chemodynamic therapy (CDT), but also serve as NIR-II photocatalysts. The photocatalytic properties synergistically elevate the level of reactive oxygen species (ROS) at the tumor site, thereby disrupting the redox homeostasis of tumor cells. Furthermore, the NIR-II photothermal characteristic of MVPs enhances the Mn<sup>2+</sup>-mediated activation of the stimulator of interferon genes (STING) pathway, endowing MVPs with antitumor immune activation capability. MVPs demonstrate excellent tumor therapeutic performance and biocompatibility in female tumor-bearing mice with a tumor inhibition rate of 85.24 %, achieving “catalysis-photothermal-immunity” synergistic antitumor activity.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123872"},"PeriodicalIF":12.9,"publicationDate":"2025-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145659819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molybdenum nanodots reprogram inflammatory-driven osteolysis via bone immune remodeling 钼纳米点通过骨免疫重塑重新编程炎症驱动的骨溶解
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-22 DOI: 10.1016/j.biomaterials.2025.123871
Zi Fu , Wanting Hao , Xichun Qin , Han Wang , Dong Xie , Meng Zhang , Dalong Ni
The translational potential of nanomedicines largely depends on compositional simplicity and scalable synthesis, with structurally intricate systems (e.g., hybrid composites) often struggling in manufacturing standardization. Single-element nanosystems bypass these limitations through inherent biosafety and bioactivity tunability. Herein, molybdenum nanodots (MoNDs), which synthesized via a facile and reproducible ultrasonic exfoliation method, were designed to address implant-associated osteolysis. These mono-component MoNDs displayed robust reactive oxygen species (ROS) scavenging and biocompatibility alongside recovering mitochondrial function to alleviate oxidative stress and curbing NF-κB-mediated M1 macrophage polarization. The MoNDs further regulated bone remodeling by suppressing osteoclastogenesis through NFATc1/CTSK downregulation and promoting osteogenic differentiation. In vivo evaluations using a titanium particle-induced osteolysis model revealed that the MoNDs effectively attenuated pathological bone loss, improved trabecular integrity, and rebalanced bone metabolic markers. Collectively, this work positions MoNDs as a clinically viable nanotherapeutic that harnesses elemental simplicity to resolve inflammation-driven osteolytic disorders, bridging material design with translational orthopedics.
纳米药物的转化潜力在很大程度上取决于成分的简单性和可扩展的合成,而结构复杂的系统(例如混合复合材料)往往在制造标准化方面挣扎。单元素纳米系统通过固有的生物安全性和生物活性可调性绕过了这些限制。本文中,钼纳米点(MoNDs)通过一种简单且可重复的超声剥离方法合成,被设计用于解决种植体相关的骨溶解。这些单组分MoNDs显示出强大的活性氧(ROS)清除能力和生物相容性,同时恢复线粒体功能,减轻氧化应激,抑制NF-κ b介导的M1巨噬细胞极化。MoNDs通过下调NFATc1/CTSK抑制破骨细胞生成,促进成骨分化,进一步调控骨重塑。使用钛颗粒诱导的骨溶解模型的体内评估显示,MoNDs有效地减轻了病理性骨丢失,改善了小梁完整性,并重新平衡了骨代谢标志物。总的来说,这项工作将MoNDs定位为临床可行的纳米疗法,利用元素简单性来解决炎症驱动的溶骨性疾病,将材料设计与转化骨科连接起来。
{"title":"Molybdenum nanodots reprogram inflammatory-driven osteolysis via bone immune remodeling","authors":"Zi Fu ,&nbsp;Wanting Hao ,&nbsp;Xichun Qin ,&nbsp;Han Wang ,&nbsp;Dong Xie ,&nbsp;Meng Zhang ,&nbsp;Dalong Ni","doi":"10.1016/j.biomaterials.2025.123871","DOIUrl":"10.1016/j.biomaterials.2025.123871","url":null,"abstract":"<div><div>The translational potential of nanomedicines largely depends on compositional simplicity and scalable synthesis, with structurally intricate systems (e.g., hybrid composites) often struggling in manufacturing standardization. Single-element nanosystems bypass these limitations through inherent biosafety and bioactivity tunability. Herein, molybdenum nanodots (MoNDs), which synthesized via a facile and reproducible ultrasonic exfoliation method, were designed to address implant-associated osteolysis. These mono-component MoNDs displayed robust reactive oxygen species (ROS) scavenging and biocompatibility alongside recovering mitochondrial function to alleviate oxidative stress and curbing NF-κB-mediated M1 macrophage polarization. The MoNDs further regulated bone remodeling by suppressing osteoclastogenesis through NFATc1/CTSK downregulation and promoting osteogenic differentiation. <em>In vivo</em> evaluations using a titanium particle-induced osteolysis model revealed that the MoNDs effectively attenuated pathological bone loss, improved trabecular integrity, and rebalanced bone metabolic markers. Collectively, this work positions MoNDs as a clinically viable nanotherapeutic that harnesses elemental simplicity to resolve inflammation-driven osteolytic disorders, bridging material design with translational orthopedics.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123871"},"PeriodicalIF":12.9,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Well-defined electronic configuration cyano-bridged bimetallic nanozyme for cancer catalytic-immunotherapy 用于癌症催化免疫治疗的定义良好的电子构型氰桥联双金属纳米酶
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-22 DOI: 10.1016/j.biomaterials.2025.123868
Qianqian Wu , Xiaohui Chen , Sitong Wang , Xing Wang , Zhixin Cha , Hengyi Chen , Yangguang Ren , Yao Luo , Xin Cui , Yan Zhao , Yufang Zhang , Yican Li , Zhongyao Ge , Sergio Benardini , Zhizeng Wang , Jichun Yang , Yang Luo
Heterobimetallic nanozymes hold great promising in cancer catalytic therapy by leveraging dual-active sites that are electronically coupled. However, their therapeutic potential is limited by high inherent complexity and lack of clarity regarding their electron conformation. In this study, we developed a ligand coordination field engineering strategy to construct a cyano-bridged bimetallic nanozyme Cu2[Fe(CN)6] (SANE) with a well-defined electronic configuration for cancer catalytic-immunotherapy. Density functional theory (DFT) calculations revealed that cyano groups, acting as strong-field bridging ligands, could form an electron delocalization network. This network, driven by electronegativity gradient of the Cu (d9) and Fe (d6) bimetallic active centers, induces synergistic distortion of d-band energy levels, which in turn enhances electron transfer and significantly improves catalytic efficiency. Furthermore, the cyano-bridging, stabilizes the structure through a strong coordination field inhibiting metal aggregation, and allowing Cu to exhibit a single-atom distribution. This further strengthens SANE catalytic therapy ability. Biomimetic modification of SANE with immunogenic tumor exosomes (iEV) enhances biocompatibility, and provides efficient Peroxidase (POD)-like and Glutathione oxidase (GSHox)-like enzymatic activities within the tumor microenvironment achieving a catalytic-immune synergistic effect. This study provides a comprehensive framework to design heterobimetallic nanozyme with ideal catalytic structure from bimetallic active sites to bridged-ligand, opening a new avenue for precisely regulating of electronic configuration in catalytic-immunotherapeutic nanoplatform.
杂双金属纳米酶利用电子偶联的双活性位点在癌症催化治疗中具有很大的前景。然而,它们的治疗潜力受到其电子构象的高固有复杂性和缺乏清晰度的限制。在这项研究中,我们开发了一种配体配位场工程策略,以构建具有明确电子构型的氰基桥接双金属纳米酶Cu2[Fe(CN)6] (SANE),用于癌症催化免疫治疗。密度泛函理论(DFT)计算表明,氰基作为强场桥接配体,可以形成电子离域网络。该网络由Cu (d9)和Fe (d6)双金属活性中心的电负性梯度驱动,诱导了d波段能级的协同畸变,从而增强了电子转移,显著提高了催化效率。此外,氰基桥接通过强大的配位场抑制金属聚集来稳定结构,并使Cu呈现单原子分布。这进一步增强了SANE的催化治疗能力。用免疫原性肿瘤外泌体(iEV)对SANE进行仿生修饰,提高了其生物相容性,并在肿瘤微环境中提供了高效的过氧化物酶(POD)样和谷胱甘肽氧化酶(GSHox)样酶活性,实现了催化-免疫协同效应。本研究为设计从双金属活性位点到桥接配体具有理想催化结构的杂双金属纳米酶提供了一个全面的框架,为催化免疫治疗纳米平台中电子构型的精确调控开辟了新的途径。
{"title":"Well-defined electronic configuration cyano-bridged bimetallic nanozyme for cancer catalytic-immunotherapy","authors":"Qianqian Wu ,&nbsp;Xiaohui Chen ,&nbsp;Sitong Wang ,&nbsp;Xing Wang ,&nbsp;Zhixin Cha ,&nbsp;Hengyi Chen ,&nbsp;Yangguang Ren ,&nbsp;Yao Luo ,&nbsp;Xin Cui ,&nbsp;Yan Zhao ,&nbsp;Yufang Zhang ,&nbsp;Yican Li ,&nbsp;Zhongyao Ge ,&nbsp;Sergio Benardini ,&nbsp;Zhizeng Wang ,&nbsp;Jichun Yang ,&nbsp;Yang Luo","doi":"10.1016/j.biomaterials.2025.123868","DOIUrl":"10.1016/j.biomaterials.2025.123868","url":null,"abstract":"<div><div>Heterobimetallic nanozymes hold great promising in cancer catalytic therapy by leveraging dual-active sites that are electronically coupled. However, their therapeutic potential is limited by high inherent complexity and lack of clarity regarding their electron conformation. In this study, we developed a ligand coordination field engineering strategy to construct a cyano-bridged bimetallic nanozyme Cu<sub>2</sub>[Fe(CN)<sub>6</sub>] (SANE) with a well-defined electronic configuration for cancer catalytic-immunotherapy. Density functional theory (DFT) calculations revealed that cyano groups, acting as strong-field bridging ligands, could form an electron delocalization network. This network, driven by electronegativity gradient of the Cu (d<sup>9</sup>) and Fe (d<sup>6</sup>) bimetallic active centers, induces synergistic distortion of d-band energy levels, which in turn enhances electron transfer and significantly improves catalytic efficiency. Furthermore, the cyano-bridging, stabilizes the structure through a strong coordination field inhibiting metal aggregation, and allowing Cu to exhibit a single-atom distribution. This further strengthens SANE catalytic therapy ability. Biomimetic modification of SANE with immunogenic tumor exosomes (iEV) enhances biocompatibility, and provides efficient Peroxidase (POD)-like and Glutathione oxidase (GSHox)-like enzymatic activities within the tumor microenvironment achieving a catalytic-immune synergistic effect. This study provides a comprehensive framework to design heterobimetallic nanozyme with ideal catalytic structure from bimetallic active sites to bridged-ligand, opening a new avenue for precisely regulating of electronic configuration in catalytic-immunotherapeutic nanoplatform.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123868"},"PeriodicalIF":12.9,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Masking macrophage injury sensing via poly I sustained release system reduces inflammation and fibrosis 通过poly I缓释系统屏蔽巨噬细胞损伤感知可减少炎症和纤维化
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-21 DOI: 10.1016/j.biomaterials.2025.123865
Keyi Chen , Xingjian You , Wei Yu , Zeng Xu , Bicheng Wang , Jinquan Ma , Xudong Zhao , Wenyu Zhang , Shatong He , Chenfei Gao , Tenghui Zhang , Wei-en Yuan , Bo Hu , Huajiang Chen
Tissue fibrosis following injury often leads to severe complications in humans. Recent research highlights that macrophage hypermigration and activation play a critical role in fibrosis development. Emerging evidence suggests that macrophage sensing of tissue injury via damage-associated molecular patterns (DAMPs) is crucial for their migration and activation. Excessive injury sensing is linked to macrophage hyperactivity, aberrant inflammation, and fibrosis. Recent studies have shown that polyinosinic acid (Poly I) can reduce macrophage activation by inhibiting signaling pathway associated with macrophage scavenger receptors (MSR). Based on this, we developed an electrospun polycaprolactone (PCL) fibrous membrane incorporating Poly I (PCL-Poly I) to ensure its early sustained release and function as an effective physical barrier. In vitro and in vivo results showed that Poly I could mask macrophage early injury sensing by downregulating MSR1/PI3K/AKT/SPP1 pathway. The local implantation of PCL-Poly I could reduce the early aggregation and activation of macrophages in the epidural fibrosis (EF) zone, thus suppressing the fibroblast activation and EF progress, with its therapeutic efficacy lasting up to 8 weeks after laminectomy. In conclusion, this study demonstrates the potential of biomaterial-based strategies to modulate immune responses, offering a novel upstream solution for treating fibrosis-related conditions.
人体损伤后的组织纤维化常导致严重的并发症。最近的研究表明,巨噬细胞的过度迁移和激活在纤维化的发展中起着关键作用。新出现的证据表明,巨噬细胞通过损伤相关分子模式(DAMPs)感知组织损伤对其迁移和激活至关重要。过度的损伤感知与巨噬细胞过度活跃、异常炎症和纤维化有关。最近的研究表明,聚肌苷酸(Poly I)可以通过抑制巨噬细胞清道夫受体(MSR)相关的信号通路来降低巨噬细胞的活化。在此基础上,我们开发了一种含有聚I (PCL-Poly I)的电纺聚己内酯(PCL)纤维膜,以确保其早期持续释放并作为有效的物理屏障。体外和体内实验结果表明Poly I可以通过下调MSR1/PI3K/AKT/SPP1通路来抑制巨噬细胞早期损伤感知。局部植入PCL-Poly I可减少硬膜外纤维化(EF)区巨噬细胞的早期聚集和活化,从而抑制成纤维细胞的活化和EF的进展,其治疗效果可持续至椎板切除术后8周。总之,这项研究证明了基于生物材料的策略调节免疫反应的潜力,为治疗纤维化相关疾病提供了一种新的上游解决方案。
{"title":"Masking macrophage injury sensing via poly I sustained release system reduces inflammation and fibrosis","authors":"Keyi Chen ,&nbsp;Xingjian You ,&nbsp;Wei Yu ,&nbsp;Zeng Xu ,&nbsp;Bicheng Wang ,&nbsp;Jinquan Ma ,&nbsp;Xudong Zhao ,&nbsp;Wenyu Zhang ,&nbsp;Shatong He ,&nbsp;Chenfei Gao ,&nbsp;Tenghui Zhang ,&nbsp;Wei-en Yuan ,&nbsp;Bo Hu ,&nbsp;Huajiang Chen","doi":"10.1016/j.biomaterials.2025.123865","DOIUrl":"10.1016/j.biomaterials.2025.123865","url":null,"abstract":"<div><div>Tissue fibrosis following injury often leads to severe complications in humans. Recent research highlights that macrophage hypermigration and activation play a critical role in fibrosis development. Emerging evidence suggests that macrophage sensing of tissue injury via damage-associated molecular patterns (DAMPs) is crucial for their migration and activation. Excessive injury sensing is linked to macrophage hyperactivity, aberrant inflammation, and fibrosis. Recent studies have shown that polyinosinic acid (Poly I) can reduce macrophage activation by inhibiting signaling pathway associated with macrophage scavenger receptors (MSR). Based on this, we developed an electrospun polycaprolactone (PCL) fibrous membrane incorporating Poly I (PCL-Poly I) to ensure its early sustained release and function as an effective physical barrier. <em>In vitro</em> and <em>in vivo</em> results showed that Poly I could mask macrophage early injury sensing by downregulating MSR1/PI3K/AKT/SPP1 pathway. The local implantation of PCL-Poly I could reduce the early aggregation and activation of macrophages in the epidural fibrosis (EF) zone, thus suppressing the fibroblast activation and EF progress, with its therapeutic efficacy lasting up to 8 weeks after laminectomy. In conclusion, this study demonstrates the potential of biomaterial-based strategies to modulate immune responses, offering a novel upstream solution for treating fibrosis-related conditions.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123865"},"PeriodicalIF":12.9,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nano-in-microalgae integrated modular hydrogel system for spatiotemporally targeted oral gene therapy of ulcerative colitis 纳米微藻集成模块化水凝胶系统用于溃疡性结肠炎的时空靶向口服基因治疗
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-21 DOI: 10.1016/j.biomaterials.2025.123862
Weili Zhao , Yixin Sun , Jiaqi Yang , Xiaoxue He , Linsheng Wu , Lili Yan , Yanfei Chen , Yanhua Liu , Yongbing Sun , Zhonggui He , Jin Sun , Qikun Jiang
Small interfering RNAs (siRNAs) have brought revolutionary advances as promising therapeutic candidates for ulcerative colitis, owing to the durable anti-inflammatory efficacy and favorable biocompatibility. Nevertheless, the clinical translation of oral siRNA therapeutics remains hindered by the harsh conditions of the gastrointestinal tract. Thus, a colon-specific modular hydrogel platform (IG@SP@FK LNPs@siTNFα) was engineered through integration of microalgal biotechnology and nanomedicines. The system comprised three functionally components: (i) a cathepsin B/glutathione (GSH) dual-responsive gemini-like cationic MA-FK-SS lipid nanoparticles core encapsulating tumor necrosis factor-α siRNA (FK LNPs@siTNFα); (ii) a negatively charged Spirulina (SP) intermediate layer (SP@FK LNPs@siTNFα); and (iii) an outer inulin-derived hydrogel (IG) coating. The IG layer provided robust protection against harsh gastrointestinal conditions and regulated the gut microbiota homeostasis. Subsequent colonic degradation of IG triggered site-specific release of SP@FK LNPs@siTNFα, which exhibited enhanced mucosal adhesion through the intrinsic helical architecture of SP. Notably, FK LNPs@siTNFα demonstrated efficient cellular internalization, proton-sponge effect-driven endosomal escape and dual-responsive siRNA release, ultimately silencing the expression of TNF-α. IG@SP@FK LNPs@siTNFα significantly attenuated the progression of ulcerative colitis via suppression of pro-inflammatory cytokine cascades (IL-6, IL-1β, TNF-α), restoration of intestinal barrier integrity, and normalization of gut microbiota homeostasis. This nano-biohybrid system established a paradigm for oral nucleic acid delivery, combining spatiotemporal control and multi-mechanistic intervention for precise gene therapy of ulcerative colitis.
小干扰rna (sirna)由于其持久的抗炎功效和良好的生物相容性,作为溃疡性结肠炎的有希望的治疗候选者带来了革命性的进展。然而,口服siRNA疗法的临床翻译仍然受到胃肠道恶劣条件的阻碍。因此,通过整合微藻生物技术和纳米药物,设计了结肠特异性模块化水凝胶平台(IG@SP@FK LNPs@siTNFα)。该系统由三个功能组件组成:(i)组织蛋白酶B/谷胱甘肽(GSH)双响应的gemini-样阳离子MA-FK-SS脂质纳米颗粒内核包裹肿瘤坏死因子-α siRNA (FK LNPs@siTNFα);(ii)带负电的螺旋藻(SP)中间层(SP@FK LNPs@siTNFα);以及(iii)外部菊粉衍生的水凝胶(IG)涂层。IG层对恶劣的胃肠道条件提供了强大的保护,并调节肠道微生物群的稳态。随后IG的结肠降解触发SP@FK LNPs@siTNFα的位点特异性释放,通过SP固有的螺旋结构表现出增强的粘膜粘附。值得注意的是,FK LNPs@siTNFα表现出有效的细胞内化,质子海绵效应驱动的内体逃逸和双响应siRNA释放,最终沉默TNF-α的表达。IG@SP@FK LNPs@siTNFα通过抑制促炎细胞因子级联反应(IL-6、IL-1β、TNF-α)、恢复肠道屏障完整性和肠道微生物群稳态正常化,显著减轻溃疡性结肠炎的进展。该纳米生物杂交系统为口腔核酸递送、时空调控和多机制干预相结合的精准基因治疗溃疡性结肠炎建立了一个范例。
{"title":"Nano-in-microalgae integrated modular hydrogel system for spatiotemporally targeted oral gene therapy of ulcerative colitis","authors":"Weili Zhao ,&nbsp;Yixin Sun ,&nbsp;Jiaqi Yang ,&nbsp;Xiaoxue He ,&nbsp;Linsheng Wu ,&nbsp;Lili Yan ,&nbsp;Yanfei Chen ,&nbsp;Yanhua Liu ,&nbsp;Yongbing Sun ,&nbsp;Zhonggui He ,&nbsp;Jin Sun ,&nbsp;Qikun Jiang","doi":"10.1016/j.biomaterials.2025.123862","DOIUrl":"10.1016/j.biomaterials.2025.123862","url":null,"abstract":"<div><div>Small interfering RNAs (siRNAs) have brought revolutionary advances as promising therapeutic candidates for ulcerative colitis, owing to the durable anti-inflammatory efficacy and favorable biocompatibility. Nevertheless, the clinical translation of oral siRNA therapeutics remains hindered by the harsh conditions of the gastrointestinal tract. Thus, a colon-specific modular hydrogel platform (IG@SP@FK LNPs@siTNFα) was engineered through integration of microalgal biotechnology and nanomedicines. The system comprised three functionally components: (i) a cathepsin B/glutathione (GSH) dual-responsive gemini-like cationic MA-FK-SS lipid nanoparticles core encapsulating tumor necrosis factor-α siRNA (FK LNPs@siTNFα); (ii) a negatively charged Spirulina (SP) intermediate layer (SP@FK LNPs@siTNFα); and (iii) an outer inulin-derived hydrogel (IG) coating. The IG layer provided robust protection against harsh gastrointestinal conditions and regulated the gut microbiota homeostasis. Subsequent colonic degradation of IG triggered site-specific release of SP@FK LNPs@siTNFα, which exhibited enhanced mucosal adhesion through the intrinsic helical architecture of SP. Notably, FK LNPs@siTNFα demonstrated efficient cellular internalization, proton-sponge effect-driven endosomal escape and dual-responsive siRNA release, ultimately silencing the expression of TNF-α. IG@SP@FK LNPs@siTNFα significantly attenuated the progression of ulcerative colitis via suppression of pro-inflammatory cytokine cascades (IL-6, IL-1β, TNF-α), restoration of intestinal barrier integrity, and normalization of gut microbiota homeostasis. This nano-biohybrid system established a paradigm for oral nucleic acid delivery, combining spatiotemporal control and multi-mechanistic intervention for precise gene therapy of ulcerative colitis.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123862"},"PeriodicalIF":12.9,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional targeting of Glypican-4 by a conformation-specific single-domain antibody 构象特异性单域抗体对Glypican-4的功能靶向
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-21 DOI: 10.1016/j.biomaterials.2025.123864
Remi Bonjean , Rossana Cuciniello , Brigitte Kerfelec , Patrick Chames , Rosanna Dono
The heparan sulphate proteoglycan, Glypican-4 (GPC-4), is an integral component of cell surfaces that fulfils key functions as a modulator of cell communication. Over time, human GPC-4 (hGPC4) has gained recognition as a valuable target for enhancing the therapeutic potential of human pluripotent stem cells (hPSCs). hGPC-4 is also a promising diagnostic and therapeutic target for a range of developmental and neurological disorders, as well as cancer. Its involvement in multiple biological processes and its impact on cellular signaling pathways make it a compelling candidate for future research and clinical applications. Here, we report RB1 and RB3 as the first hGPC-4-specific nanobodies. Both RB3 and RB1, bind recombinant hGPC4 with affinities in the tens of nanomolar range, whereas only RB1 recognizes native, cell-expressed hGPC4, highlighting its potential for functional studies. Notably, the bivalent nanobody Fc-fusion form of RB1, termed RB1-Fc, demonstrates a significant ∼14-fold increase in apparent binding affinity on cells when compared to the monovalent RB1. Furthermore, binding of RB1-Fc to hGPC-4 is dependent on the native conformation of hGPC-4, demonstrating that RB1-Fc is a conformational nanobody. Notably, RB1-Fc neutralizes the activity of GPC-4, as shown by our functional studies in hPSCs. These studies demonstrate the potent efficacy of the lead hGPC4 nanobodies, RB1-Fc and RB3. They also provide a solid rationale for using these nanobodies in the detection and characterization of physiologically and clinically relevant hGPC-4. Additionally, their potential as agents for therapeutic targeting of hGPC-4 opens new avenues for treating disorders associated with dysregulated hGPC-4 activity.
硫酸肝素蛋白聚糖Glypican-4 (GPC-4)是细胞表面的一个组成部分,作为细胞通讯的调节剂发挥关键作用。随着时间的推移,人类GPC-4 (hGPC4)已被认为是增强人类多能干细胞(hPSCs)治疗潜力的有价值靶点。hGPC-4也是一种有前景的诊断和治疗靶点,用于一系列发育和神经疾病以及癌症。它参与多种生物过程及其对细胞信号通路的影响使其成为未来研究和临床应用的引人注目的候选者。在这里,我们报道了RB1和RB3作为第一个hgpc -4特异性纳米体。RB3和RB1结合重组hGPC4的亲和力在几十纳摩尔范围内,而只有RB1识别天然的细胞表达的hGPC4,突出了其功能研究的潜力。值得注意的是,RB1的二价纳米体fc融合形式,称为RB1- fc,与单价RB1相比,对细胞的表观结合亲和力显著增加~ 14倍。此外,RB1-Fc与hGPC-4的结合依赖于hGPC-4的天然构象,这表明RB1-Fc是一个构象纳米体。值得注意的是,RB1-Fc中和GPC-4的活性,正如我们在hPSCs中的功能研究所显示的那样。这些研究证明了hGPC4先导纳米体RB1-Fc和RB3的有效作用。它们也为使用这些纳米体检测和表征生理和临床相关的hGPC-4提供了坚实的理论基础。此外,它们作为靶向治疗hGPC-4的潜在药物,为治疗与hGPC-4活性失调相关的疾病开辟了新的途径。
{"title":"Functional targeting of Glypican-4 by a conformation-specific single-domain antibody","authors":"Remi Bonjean ,&nbsp;Rossana Cuciniello ,&nbsp;Brigitte Kerfelec ,&nbsp;Patrick Chames ,&nbsp;Rosanna Dono","doi":"10.1016/j.biomaterials.2025.123864","DOIUrl":"10.1016/j.biomaterials.2025.123864","url":null,"abstract":"<div><div>The heparan sulphate proteoglycan, Glypican-4 (GPC-4), is an integral component of cell surfaces that fulfils key functions as a modulator of cell communication. Over time, human GPC-4 (hGPC4) has gained recognition as a valuable target for enhancing the therapeutic potential of human pluripotent stem cells (hPSCs). hGPC-4 is also a promising diagnostic and therapeutic target for a range of developmental and neurological disorders, as well as cancer. Its involvement in multiple biological processes and its impact on cellular signaling pathways make it a compelling candidate for future research and clinical applications. Here, we report RB1 and RB3 as the first hGPC-4-specific nanobodies. Both RB3 and RB1, bind recombinant hGPC4 with affinities in the tens of nanomolar range, whereas only RB1 recognizes native, cell-expressed hGPC4, highlighting its potential for functional studies. Notably, the bivalent nanobody Fc-fusion form of RB1, termed RB1-Fc, demonstrates a significant ∼14-fold increase in apparent binding affinity on cells when compared to the monovalent RB1. Furthermore, binding of RB1-Fc to hGPC-4 is dependent on the native conformation of hGPC-4, demonstrating that RB1-Fc is a conformational nanobody. Notably, RB1-Fc neutralizes the activity of GPC-4, as shown by our functional studies in hPSCs. These studies demonstrate the potent efficacy of the lead hGPC4 nanobodies, RB1-Fc and RB3. They also provide a solid rationale for using these nanobodies in the detection and characterization of physiologically and clinically relevant hGPC-4. Additionally, their potential as agents for therapeutic targeting of hGPC-4 opens new avenues for treating disorders associated with dysregulated hGPC-4 activity.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123864"},"PeriodicalIF":12.9,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophage-to-myofibroblast transition (MMT) – An adverse response to polypropylene mesh implanted for pelvic organ prolapse repair surgery in a non-human primate model 巨噬细胞向肌成纤维细胞转化(MMT)——在非人灵长类动物模型中,用于盆腔器官脱垂修复手术的聚丙烯网片植入后的不良反应
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-19 DOI: 10.1016/j.biomaterials.2025.123861
Marrisa A. Therriault , Katrina Knight , Srividya Kottapalli , Temitope Obisesan , Malini Harinath , Bryan N. Brown , Pamela A. Moalli
Surgical repair of pelvic organ prolapse (POP) is often augmented by polypropylene mesh to provide mechanical support to the vagina and improve anatomical outcomes as compared to native tissue repair. However, POP repair surgeries utilizing PPM have complications (most often pain or mesh exposure into the vagina) in over 10% of cases. Previous work has demonstrated that tensioning of meshes with certain geometries (diamond and hexagon pores), results in both planar (pore collapse) and nonplanar (wrinkles) deformations, significantly altering textile properties and impacting the host response. To further investigate the impact of mesh deformation on the host response, we implanted mesh in a validated non-human primate model via sacrocolpopexy with stable flat (square pores, N = 20) versus deformed geometries (mesh loaded on the diamond prior to implantation resulting in collapsed pores and wrinkles, N = 20). To investigate the impact of tension independent of deformation, we implanted on and off tension (10 N, N = 10 in each group). We hypothesized that more stable geometries trigger a healing response that achieves homeostasis while deformed mesh, by increasing the amount of material in contact with the host, triggers a maladaptive remodeling response with the formation of myofibroblasts. After twelve weeks, we found that mesh deformations and the absence of tension increase the amount of mesh per area on the vagina (mesh burden) and reproduced clinical complications (mesh exposure and vaginal thinning). Interestingly, MMT cells, or myofibroblasts co-expressing a macrophage marker (CD68), were seen to significantly increase in response to mesh burden, as well as respond hyper-locally to the mesh fiber interface. We observed decreased collagen density and more immature matrix deposited in conditions with higher MMT cell presence, showing more disorganization in deposited matrix with increased mesh burden, and the loss of tension. TGF-β1, in both active and latent forms, increased with increasing mesh burden, and highest expression was observed in conditions precipitating the highest percentage of MMT cells, a possible mechanism of transdifferentiation. This study showed the importance of PPM mesh properties on mesh burden following tensioning, impact on MMT transdifferentiation, and the downstream effect of these changes on the host response and healing outcomes.
手术修复盆腔器官脱垂(POP)通常增加聚丙烯网提供机械支持阴道和改善解剖结果相比,原生组织修复。然而,使用PPM的POP修复手术在超过10%的病例中会出现并发症(最常见的是疼痛或补片暴露在阴道内)。先前的研究表明,拉伸具有特定几何形状(菱形和六边形孔隙)的网格,会导致平面(孔隙塌陷)和非平面(褶皱)变形,从而显著改变纺织品的性能并影响宿主的响应。为了进一步研究网格变形对宿主反应的影响,我们通过骶colpop固定术将网格植入一个经过验证的非人灵长类动物模型中,该模型具有稳定的平面(方形孔,N = 20)和变形的几何形状(植入前网格加载在金刚石上,导致孔塌陷和皱纹,N = 20)。为了研究张力与变形无关的影响,我们植入开启和关闭张力(10 N,每组N = 10)。我们假设,更稳定的几何形状会触发愈合反应,从而实现体内平衡,而变形的网状结构,通过增加与宿主接触的材料量,会引发肌成纤维细胞形成的不适应重塑反应。12周后,我们发现网片变形和张力缺失增加了阴道上每个区域的网片数量(网片负担),并重现了临床并发症(网片暴露和阴道变薄)。有趣的是,MMT细胞,或共表达巨噬细胞标记物(CD68)的肌成纤维细胞,对网状纤维负荷的反应显著增加,以及对网状纤维界面的超局部反应。我们观察到胶原密度降低,在MMT细胞存在较高的条件下沉积的基质更不成熟,沉积的基质更疏松,网状负荷增加,张力丧失。TGF-β1的活性和潜伏形式均随着网状负荷的增加而增加,在MMT细胞比例最高的条件下表达量最高,这可能是转分化的机制。这项研究显示了PPM网状物特性对网状物张力后负荷的重要性,对MMT转分化的影响,以及这些变化对宿主反应和愈合结果的下游影响。
{"title":"Macrophage-to-myofibroblast transition (MMT) – An adverse response to polypropylene mesh implanted for pelvic organ prolapse repair surgery in a non-human primate model","authors":"Marrisa A. Therriault ,&nbsp;Katrina Knight ,&nbsp;Srividya Kottapalli ,&nbsp;Temitope Obisesan ,&nbsp;Malini Harinath ,&nbsp;Bryan N. Brown ,&nbsp;Pamela A. Moalli","doi":"10.1016/j.biomaterials.2025.123861","DOIUrl":"10.1016/j.biomaterials.2025.123861","url":null,"abstract":"<div><div>Surgical repair of pelvic organ prolapse (POP) is often augmented by polypropylene mesh to provide mechanical support to the vagina and improve anatomical outcomes as compared to native tissue repair. However, POP repair surgeries utilizing PPM have complications (most often pain or mesh exposure into the vagina) in over 10% of cases. Previous work has demonstrated that tensioning of meshes with certain geometries (diamond and hexagon pores), results in both planar (pore collapse) and nonplanar (wrinkles) deformations, significantly altering textile properties and impacting the host response. To further investigate the impact of mesh deformation on the host response, we implanted mesh in a validated non-human primate model via sacrocolpopexy with stable flat (square pores, N = 20) versus deformed geometries (mesh loaded on the diamond prior to implantation resulting in collapsed pores and wrinkles, N = 20). To investigate the impact of tension independent of deformation, we implanted on and off tension (10 N, N = 10 in each group). We hypothesized that more stable geometries trigger a healing response that achieves homeostasis while deformed mesh, by increasing the amount of material in contact with the host, triggers a maladaptive remodeling response with the formation of myofibroblasts. After twelve weeks, we found that mesh deformations and the absence of tension increase the amount of mesh per area on the vagina (mesh burden) and reproduced clinical complications (mesh exposure and vaginal thinning). Interestingly, MMT cells, or myofibroblasts co-expressing a macrophage marker (CD68), were seen to significantly increase in response to mesh burden, as well as respond hyper-locally to the mesh fiber interface. We observed decreased collagen density and more immature matrix deposited in conditions with higher MMT cell presence, showing more disorganization in deposited matrix with increased mesh burden, and the loss of tension. TGF-β1, in both active and latent forms, increased with increasing mesh burden, and highest expression was observed in conditions precipitating the highest percentage of MMT cells, a possible mechanism of transdifferentiation. This study showed the importance of PPM mesh properties on mesh burden following tensioning, impact on MMT transdifferentiation, and the downstream effect of these changes on the host response and healing outcomes.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123861"},"PeriodicalIF":12.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target anesthesia and surgery induced senescent cell via composite microsphere hydrogels as nose-to-brain amplifiers of platelet factor 4 delivery for neurocognitive dysfunction repair 复合微球水凝胶用于麻醉和手术诱导的衰老细胞鼻到脑的血小板因子4输送放大器修复神经认知功能障碍。
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-19 DOI: 10.1016/j.biomaterials.2025.123863
Zheng Xie , Zehao Chen , Weifeng Wu , Miaomiao Fei , Wenting Li , Silu Cao , Nan Wang , Xiaoyue Xu , Xiaoxiao Sun , Qiang Liu , Xiao-fei Gao , Cheng Li
Perioperative neurocognitive disorder (PND) is a common complication in older surgical patients, leading to increased neurodegenerative and death risk, augment socioeconomic burdens. Despite its prevalence, the reasons of why this complication occurs highly in older, underlying pathogenesis mechanisms, and effective treatments remain unclear. Senescence associated secretory phenotype (SASP), resulting from cellular senescence, drives inflammaging and cognitive decline. However, the association between cellular senescent and poor cognitive outcome is seldomly defined in PND. Herein, we showed that anesthesia and surgery in aged mice further increase hippocampal neuron senescent burden, manifest as increased senescence-like markers (CDKN2A/p16, CDKN1A/p21, SASP, SA-β-Gal), along with lipofuscin and lipid droplet accumulation and synaptic dysfunction. We identified elevated PF4, a platelet-derived factor, as a defensive response in older PND mice. Intraperitoneal PF4 administration mitigated neuronal senescence burden and improved cognitive dysfunction. Considering the older, frail patients and shorter perioperative period, we developed microfluidic hydrogel microspheres and cationic thermosensitive hydrogel complexes for nasal PF4 delivery enabling satisfy minimally invasive, less frequent dosing and sustained treatment. These findings reveal a critical role for cellular senescence in PND and propose PF4-based therapies as a promising translational strategy.
围手术期神经认知障碍(PND)是老年外科患者的常见并发症,导致神经退行性和死亡风险增加,增加了社会经济负担。尽管发病率很高,但这种并发症在老年人中高发的原因、潜在的发病机制和有效的治疗方法仍不清楚。衰老相关分泌表型(SASP)是由细胞衰老引起的,可导致炎症和认知能力下降。然而,在PND中,细胞衰老和认知能力差之间的关系很少被定义。在此,我们发现麻醉和手术在老年小鼠中进一步增加了海马神经元的衰老负担,表现为衰老样标志物(CDKN2A/p16, CDKN1A/p21, SASP, SA-β-Gal)的增加,以及脂质和脂滴的积累和突触功能障碍。我们发现PF4(一种血小板衍生因子)升高是老年PND小鼠的一种防御反应。腹腔注射PF4可减轻神经元衰老负担,改善认知功能障碍。考虑到患者年龄大、体弱、围手术期短,我们开发了微流控水凝胶微球和阳离子热敏水凝胶复合物用于经鼻给药PF4,可满足微创、给药频率低、持续治疗的要求。这些发现揭示了细胞衰老在PND中的关键作用,并提出了基于pf4的治疗作为一种有希望的转化策略。
{"title":"Target anesthesia and surgery induced senescent cell via composite microsphere hydrogels as nose-to-brain amplifiers of platelet factor 4 delivery for neurocognitive dysfunction repair","authors":"Zheng Xie ,&nbsp;Zehao Chen ,&nbsp;Weifeng Wu ,&nbsp;Miaomiao Fei ,&nbsp;Wenting Li ,&nbsp;Silu Cao ,&nbsp;Nan Wang ,&nbsp;Xiaoyue Xu ,&nbsp;Xiaoxiao Sun ,&nbsp;Qiang Liu ,&nbsp;Xiao-fei Gao ,&nbsp;Cheng Li","doi":"10.1016/j.biomaterials.2025.123863","DOIUrl":"10.1016/j.biomaterials.2025.123863","url":null,"abstract":"<div><div>Perioperative neurocognitive disorder (PND) is a common complication in older surgical patients, leading to increased neurodegenerative and death risk, augment socioeconomic burdens. Despite its prevalence, the reasons of why this complication occurs highly in older, underlying pathogenesis mechanisms, and effective treatments remain unclear. Senescence associated secretory phenotype (SASP), resulting from cellular senescence, drives inflammaging and cognitive decline. However, the association between cellular senescent and poor cognitive outcome is seldomly defined in PND. Herein, we showed that anesthesia and surgery in aged mice further increase hippocampal neuron senescent burden, manifest as increased senescence-like markers (CDKN2A/p16, CDKN1A/p21, SASP, SA-β-Gal), along with lipofuscin and lipid droplet accumulation and synaptic dysfunction. We identified elevated PF4, a platelet-derived factor, as a defensive response in older PND mice. Intraperitoneal PF4 administration mitigated neuronal senescence burden and improved cognitive dysfunction. Considering the older, frail patients and shorter perioperative period, we developed microfluidic hydrogel microspheres and cationic thermosensitive hydrogel complexes for nasal PF4 delivery enabling satisfy minimally invasive, less frequent dosing and sustained treatment. These findings reveal a critical role for cellular senescence in PND and propose PF4-based therapies as a promising translational strategy.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123863"},"PeriodicalIF":12.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145601603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Lactate metabolism regulating nanosystem synergizes cuproptosis and ferroptosis to enhance cancer immunotherapy” [Biomaterials 325 (2026) 123538] “乳酸代谢调节纳米系统协同铜下沉和铁下沉以增强癌症免疫治疗”的更正[生物材料325(2026)123538]。
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-17 DOI: 10.1016/j.biomaterials.2025.123859
Hui Zhi , Weimin Yin , Shiyu Chen , Xiaoyou Zhang , Zichen Yang , Fulong Man , Rongjie Li , Yanni Cai , Yang Li , Caoyi You , Yan Li , Yongyong Li , Haiqing Dong
{"title":"Corrigendum to “Lactate metabolism regulating nanosystem synergizes cuproptosis and ferroptosis to enhance cancer immunotherapy” [Biomaterials 325 (2026) 123538]","authors":"Hui Zhi ,&nbsp;Weimin Yin ,&nbsp;Shiyu Chen ,&nbsp;Xiaoyou Zhang ,&nbsp;Zichen Yang ,&nbsp;Fulong Man ,&nbsp;Rongjie Li ,&nbsp;Yanni Cai ,&nbsp;Yang Li ,&nbsp;Caoyi You ,&nbsp;Yan Li ,&nbsp;Yongyong Li ,&nbsp;Haiqing Dong","doi":"10.1016/j.biomaterials.2025.123859","DOIUrl":"10.1016/j.biomaterials.2025.123859","url":null,"abstract":"","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"327 ","pages":"Article 123859"},"PeriodicalIF":12.9,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145547491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flexoelectricity-boosted core-shell nanoparticles with self-amplified Fenton-like activity for tumor piezocatalytic immunotherapy 具有自扩增芬顿样活性的柔性电增强核壳纳米颗粒用于肿瘤压电催化免疫治疗。
IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-15 DOI: 10.1016/j.biomaterials.2025.123856
Peiran Chen , Chao Qi , Ke Zhang , Shupeng Wang , Xiaotong Lu , Kun Qian , Mingyue Zhang , Shiyao Guo , Yuhong Zhuo , Chenguo Yao , Kaiyong Cai
Piezocatalytic therapy, which utilizes ultrasonic activation of piezoelectric materials to generate reactive oxygen species (ROS), holds significant potential. However, its efficacy is constrained by the limited ROS generation capacity of piezoelectric materials. In this study, a gradient ion replacement strategy was employed to construct CuxBa1-xTiO3-shell structured BaTiO3 (Cu-BTO) piezoelectric materials with flexoelectric properties. This process induces the BTO surface to transition from a crystalline state to an amorphous state and subsequently recrystallize. The phase transformation introduces flexoelectric properties in Cu-BTO surface, while the disparity in ionic radii between Cu2+ and Ba2+ enhances lattice asymmetry. Consequently, Cu-BTO exhibits significantly enhanced piezoelectric and piezocatalytic properties, with the d33 value reaching 129.91 pm/V, representing an increase of 345.93 %. Under ultrasonic stimulation, Cu-BTO can not only directly generate OH and H2O2 through piezocatalysis, but also achieve self-amplified Fenton-like catalysis and GSH depletion by promoting charge transfer via the built-in electric field. The strong oxidative stress induces severe immunogenic cell death (ICD) of tumor cells, and triggers a series of antitumor immune responses such as dendritic cell (DC) maturation and T cell activation. Ultimately, an 83.7 % tumor inhibition rate is achieved, and lung metastasis of the tumor is effectively prevented. This work not only demonstrates a method to describes a method for inducing the flexoelectric effect in piezoelectric nanomaterials but also provides novel insights into the design and optimization of piezoelectric nanomaterials.
压电催化疗法利用超声波激活压电材料产生活性氧(ROS),具有巨大的潜力。然而,其有效性受到压电材料ROS生成能力的限制。本研究采用梯度离子置换策略,构建了具有挠曲电性能的cuxba1 - xtio3壳结构BaTiO3 (Cu-BTO)压电材料。该过程诱导BTO表面从晶态转变为非晶态并随后再结晶。Cu-BTO表面的相变引入了挠曲电性质,而Cu2+和Ba2+之间离子半径的差异增强了晶格的不对称性。结果表明,Cu-BTO的压电和压催化性能显著增强,d33值达到129.91 pm/V,提高了345.93%。在超声刺激下,Cu-BTO不仅可以通过压电催化直接生成•OH和H2O2,还可以通过内置电场促进电荷转移实现自放大的类芬顿催化和GSH消耗。强氧化应激诱导肿瘤细胞发生严重的免疫原性细胞死亡(ICD),引发树突状细胞(DC)成熟和T细胞活化等一系列抗肿瘤免疫反应。最终达到83.7%的肿瘤抑制率,有效防止了肿瘤的肺转移。这项工作不仅展示了一种描述在压电纳米材料中诱导柔性电效应的方法,而且为压电纳米材料的设计和优化提供了新的见解。
{"title":"Flexoelectricity-boosted core-shell nanoparticles with self-amplified Fenton-like activity for tumor piezocatalytic immunotherapy","authors":"Peiran Chen ,&nbsp;Chao Qi ,&nbsp;Ke Zhang ,&nbsp;Shupeng Wang ,&nbsp;Xiaotong Lu ,&nbsp;Kun Qian ,&nbsp;Mingyue Zhang ,&nbsp;Shiyao Guo ,&nbsp;Yuhong Zhuo ,&nbsp;Chenguo Yao ,&nbsp;Kaiyong Cai","doi":"10.1016/j.biomaterials.2025.123856","DOIUrl":"10.1016/j.biomaterials.2025.123856","url":null,"abstract":"<div><div>Piezocatalytic therapy, which utilizes ultrasonic activation of piezoelectric materials to generate reactive oxygen species (ROS), holds significant potential. However, its efficacy is constrained by the limited ROS generation capacity of piezoelectric materials. In this study, a gradient ion replacement strategy was employed to construct Cu<sub>x</sub>Ba<sub>1-x</sub>TiO<sub>3</sub>-shell structured BaTiO<sub>3</sub> (Cu-BTO) piezoelectric materials with flexoelectric properties. This process induces the BTO surface to transition from a crystalline state to an amorphous state and subsequently recrystallize. The phase transformation introduces flexoelectric properties in Cu-BTO surface, while the disparity in ionic radii between Cu<sup>2+</sup> and Ba<sup>2+</sup> enhances lattice asymmetry. Consequently, Cu-BTO exhibits significantly enhanced piezoelectric and piezocatalytic properties, with the <em>d</em><sub><em>33</em></sub> value reaching 129.91 pm/V, representing an increase of 345.93 %. Under ultrasonic stimulation, Cu-BTO can not only directly generate <sup>•</sup>OH and H<sub>2</sub>O<sub>2</sub> through piezocatalysis, but also achieve self-amplified Fenton-like catalysis and GSH depletion by promoting charge transfer via the built-in electric field. The strong oxidative stress induces severe immunogenic cell death (ICD) of tumor cells, and triggers a series of antitumor immune responses such as dendritic cell (DC) maturation and T cell activation. Ultimately, an 83.7 % tumor inhibition rate is achieved, and lung metastasis of the tumor is effectively prevented. This work not only demonstrates a method to describes a method for inducing the flexoelectric effect in piezoelectric nanomaterials but also provides novel insights into the design and optimization of piezoelectric nanomaterials.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"328 ","pages":"Article 123856"},"PeriodicalIF":12.9,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145555908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomaterials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1